BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

817 related articles for article (PubMed ID: 24952903)

  • 1. Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing.
    Heckl D; Kowalczyk MS; Yudovich D; Belizaire R; Puram RV; McConkey ME; Thielke A; Aster JC; Regev A; Ebert BL
    Nat Biotechnol; 2014 Sep; 32(9):941-6. PubMed ID: 24952903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of novel Il2rg-knockout mice with clustered regularly interspaced short palindromic repeats (CRISPR) and Cas9.
    Byambaa S; Uosaki H; Hara H; Nagao Y; Abe T; Shibata H; Nureki O; Ohmori T; Hanazono Y
    Exp Anim; 2020 Apr; 69(2):189-198. PubMed ID: 31801915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
    Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
    Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient genome editing of Brassica campestris based on the CRISPR/Cas9 system.
    Xiong X; Liu W; Jiang J; Xu L; Huang L; Cao J
    Mol Genet Genomics; 2019 Oct; 294(5):1251-1261. PubMed ID: 31129735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimisation of the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 : single-guide RNA (sgRNA) delivery system in a goat model.
    Huang Y; Ding Y; Liu Y; Zhou S; Ding Q; Yan H; Ma B; Zhao X; Wang X; Chen Y
    Reprod Fertil Dev; 2019 Aug; 31(9):1533-1537. PubMed ID: 31079595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing CRISPR/Cas9 for in situ functional assays.
    Malina A; Mills JR; Cencic R; Yan Y; Fraser J; Schippers LM; Paquet M; Dostie J; Pelletier J
    Genes Dev; 2013 Dec; 27(23):2602-14. PubMed ID: 24298059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of Gene-Edited Chrysanthemum morifolium Using Multicopy Transgenes as Targets and Markers.
    Kishi-Kaboshi M; Aida R; Sasaki K
    Plant Cell Physiol; 2017 Feb; 58(2):216-226. PubMed ID: 28049122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.
    Hendel A; Bak RO; Clark JT; Kennedy AB; Ryan DE; Roy S; Steinfeld I; Lunstad BD; Kaiser RJ; Wilkens AB; Bacchetta R; Tsalenko A; Dellinger D; Bruhn L; Porteus MH
    Nat Biotechnol; 2015 Sep; 33(9):985-989. PubMed ID: 26121415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of Latent HIV-1 Proviral DNA Using Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Treatment and the Assessment of Off-Target Effects.
    Xu Y; Peng X; Zheng Y; Jin C; Lu X; Han D; Fu H; Chen C; Wu N
    Front Microbiol; 2021; 12():629153. PubMed ID: 34122355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Genome-Editing Nanomachine Constructed with a Clustered Regularly Interspaced Short Palindromic Repeats System and Activated by Near-Infrared Illumination.
    Peng H; Le C; Wu J; Li XF; Zhang H; Le XC
    ACS Nano; 2020 Mar; 14(3):2817-2826. PubMed ID: 32048826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR Gene Therapy of the Eye: Targeted Knockout of Vegfa in Mouse Retina by Lentiviral Delivery.
    Holmgaard A; Alsing S; Askou AL; Corydon TJ
    Methods Mol Biol; 2019; 1961():307-328. PubMed ID: 30912054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEG-Delivered CRISPR-Cas9 Ribonucleoproteins System for Gene-Editing Screening of Maize Protoplasts.
    Sant'Ana RRA; Caprestano CA; Nodari RO; Agapito-Tenfen SZ
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32887261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of CRISPR-Cas9 genome editing for constructing animal models of human diseases].
    Ou Z; Sun X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Aug; 33(4):559-63. PubMed ID: 27455021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of Three Prominent Mutations in Mouse and Human Models of Duchenne Muscular Dystrophy by Single-Cut Genome Editing.
    Min YL; Chemello F; Li H; Rodriguez-Caycedo C; Sanchez-Ortiz E; Mireault AA; McAnally JR; Shelton JM; Zhang Y; Bassel-Duby R; Olson EN
    Mol Ther; 2020 Sep; 28(9):2044-2055. PubMed ID: 32892813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
    Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
    Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CFTR inactivation by lentiviral vector-mediated RNA interference and CRISPR-Cas9 genome editing in human airway epithelial cells.
    Bellec J; Bacchetta M; Losa D; Anegon I; Chanson M; Nguyen TH
    Curr Gene Ther; 2015; 15(5):447-59. PubMed ID: 26264708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse Models of Myeloid Malignancies.
    Basheer F; Vassiliou G
    Cold Spring Harb Perspect Med; 2021 Jan; 11(1):. PubMed ID: 32071146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing.
    Tang YD; Guo JC; Wang TY; Zhao K; Liu JT; Gao JC; Tian ZJ; An TQ; Cai XH
    FASEB J; 2018 Aug; 32(8):4293-4301. PubMed ID: 29509513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.